- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on IDH1 R132C in Canada
Total 7 results
-
Rigel PharmaceuticalsNationwide Children's HospitalNot yet recruitingAstrocytoma | High Grade Glioma | Oligodendroglioma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | Spinal Tumor | Astrocytoma, Grade III | Astrocytoma, Grade IV | IDH1 Mutation | WHO Grade IV Glioma | Thalamus Tumor | IDH1 R132 | IDH1 R132C | IDH1 R132H and other conditionsUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
University Health Network, TorontoAbbVie; CelgeneTerminatedAcute Myeloid Leukemia | Relapsed Cancer | Refractory Cancer | IDH2 Gene MutationCanada
-
University Health Network, TorontoRecruitingGlioma | Solid Tumor | Cholangiocarcinoma | IDH MutationCanada
-
Ottawa Hospital Research InstituteRecruiting
-
Sunnybrook Health Sciences CentreRecruitingGlioblastoma, IDH-mutant | Glioblastoma Multiforme, AdultCanada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruiting
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada